Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Company type

    Whole-cell allogenic vaccines for cancer. Acquired by VaxOnco Inc.

    Funding rounds

    (1 May 2006)

    Profile Country Notes
    3i Group PLC Major, long established, quoted private equity investor United Kingdom


    Profile Country Notes
    Excalibur Fund Managers Ltd United Kingdom

    Current and past shareholders

    Investor Contacts Round
    3i Group PLC logo 3i Group PLC
    Major, long established, quoted private equity investor
    Series C
    Excalibur Fund Managers Ltd logo Excalibur Fund Managers Ltd
    +44 (20) 7887-7642
    N/A